NexImmune Establishes Research Initiative with City of Hope to Focus on Novel Immunotherapeutic Approaches to Acute Myeloid Leukemia

NEXT STORY
RespireRx Pharmaceuticals Inc. Announces Appointment of Dr. James Cook and Dr. Jeffrey Witkin as Research Fellows
PREV STORY
Immune Health Supplements Market Worth USD 29.40 Billion at 7.4% CAGR; Rapid Changes in Lifestyles to Bolster Growth, says Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aduro Biotech Reports Third Quarter 2016 Financial Results

BERKELEY, Calif., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported ...

author_avatar
NASDAQ Market News

FFF Enterprises Celebrates 28 Years of Innovation and Excellence

TEMECULA, CA--(Marketwired - July 08, 2016) - On July 8, 2016, FFF Enterprises, Inc. ...

author_avatar
NASDAQ Market News

HIMSS Analytics Honors Pagosa Springs Medical Center with Stage 7 Recognition

PAGOSA SPRINGS, Colo., March 02, 2018 (GLOBE NEWSWIRE) -- Pagosa Springs Medical Center (PSMC) ...

author_avatar
NASDAQ Market News